nurs 1950: pharmacology i 1. objective 1: describe the relationship of calcium to electrical...
TRANSCRIPT
1
CARDIOTONICS AND CORONARY VASODILATORS
NURS 1950: Pharmacology I
2
Objective 1: describe the relationship of calcium to electrical activity of the heart
Resting: Preload: Afterload:
3
Heart dependent upon influx of calcium Ca+ enters channels in the cardiac cell
membrane and go into the cell along with Na
K+ comes out Cardiac cells contract
repolarization
4
Objective 2: describe how the ANS affects the heart rate
5
The ANS is the primary controller of heart rate
Cholinergic (parasympathetic) vagal fibers are close to the SA node
Stimulation with acetylcholine slows the heart rate
6
Sympathetic (adrenergic) nerves also innervate the heart
Stimulation causes norepinephrine to be released.
Increases heart rate, slows refractory period
7
8
Objective 3: describe how cardiac drugs affect cardiac action
9
1. Increase or decrease the force of myocardial action
Positive inotropics Negative inotropics
How cardiac drugs work
10
2. Increase or decrease heart rate by altering SA node impulse conduction
Positive chronotropics Negative chronotropics
11
3. Increase or decrease conduction of AV impulses
Positive dromotropics Negative dromotropics
12
Diuretics to decrease blood volume
13
Objective 4: identify the action of cardiac glycosides
14
Digoxin & relatives come from Natural sources Helpful in CHF Have a positive inotropic effect
Cardiac glycosides
15
Increases mechanical efficiency of heart This pumps more blood With increased blood to kidneys, diuresis
occurs, edema reduced Cardiac glycosides also have negative
chronotropic effect, Negative dromotropic effect
16
Action Thought that they cause release of free
calcium within the cardiac muscle cell Also change the electrical activity of
myocardium
17
Decrease velocity of electrical conduction, prolong refractory period in AV conduction system
Increase vagal tone
18
Objective 5: relate how the effects of digitalis are beneficial to the client with CHF
Recall the signs/symptoms of CHF How do you think cardiac glycosides
improve this condition?
19
Objective 6: describe the usefulness of digitalis in the treatment of atrial fibrillation
20
What is atrial fibrillation? What activity of the cardiac glycosides
improve this condition?
21
Chronotropic/dromotropic effects◦ Suppress impulse conduction through the AV node◦ This prevents excessive atrial activity from
reaching ventricles
22
Objective 7: list the generic and brand names of the digitalis preparations
Digitalis preparations similar in pharmacological properties, toxic effects
23
Digoxin (Lanoxin, Lanoxicaps): oral or IV Onset 30-120 minutes oral Peaks 2-6 hrs Duration 2-4 days Eliminated by kidney
◦ Used most often as rapid onset, short duration
Prototype
24
Must take apical pulse 1 minute before administration
Hold if under 60, contact MD Blood levels needed
25
Objective 8: define digitalization
26
Digitalization is the administration of digitalis that is more than the maintenance dose
This raises the blood level quickly to therapeutic range◦ May also be called a loading dose
27
Example◦ Oral dose of digoxin 0.5-0.75 mg◦ 0.25-0.5 mg then given every 6-8 hours until
desired blood level reached◦ Then maintenance dose: 0.125-0.5 mg daily
28
Objective 9: list symptoms of digitalis toxicity
29
Digitalis toxicity:◦GI distress: N/V, anorexia, and/or diarrhea (flu like symptoms)
◦May have excessive salivation and abdominal pain
◦Neurological: restless, irritable, lethargy, drowsiness, and/or confusion
30
May have vision changes, changes in color◦May have halos, amblyopia and diplopia
◦Cardiac effects: development of arrhythmias (bradycardia, primary AV block)
31
Objective 10: identify factors which predispose digitalis toxicity
32
Toxicity predisposition: hypokalemia as cardiac muscles more sensitive to the glycosides
Renal impairment as 60-90% excreted by kidney
IV administration: rapid accumulation can occur
Contraindications
33
Treatment◦ Hold the drug◦ Use digoxin immune fab (Digibind)
Antigen-binding fragments combine with digoxin to neutralize its action
34
Objective 11: describe the nursing responsibilities associated with administering cardiac glycosides preparations
35
Take apical pulse 1 full minute Hold if under 60, over 100 in adults Report any evidence of irregular rhythm Observe for toxicity S/S Monitor K+ if on diuretics Encourage K+ rich foods
36
Teach client to take pulse Teach S/S of toxicity If hypothyroid, sensitive to digitalis Draw blood levels periodically
37
Atherosclerosis narrows heart’s vessels Blood flow impeded Demand exceeds supply = anginal pain
Angina
38
Objective 12: describe the actions of the antianginal drugs
39
Drugs are used to dilate coronary arteries This brings in oxygen and nutrients Supply = demand so no pain
Goals
40
Objective 13: identify the drugs used to treat angina pectoris
41
Nitroglycerin Calcium channel blockers Beta blockers ACE inhibitors
42
Nitroglycerin drugs Works by relaxing arterial and venous
smooth muscle Dilate coronary arteries
43
Liquid nitroglycerin unstable, highly volatile Oral tablets stable, non-explosive Can be given sublingual for rapid,
predictable action Can be transmucosal, aerosol translingual
spray, IV, transdermal
44
Transdermal
45
Ointment: placed on paper with inches marked off
Amount prescribed placed on the paper, taped into place
4-8 hours of action (Nitro-bid, Nitrol)
46
Nitroglycerin patches: worn 12-14 hours “Patch-off” period of 6-12 hours Prevents tolerance (Transderm-Nitro, Nitro-Dur)
47
IV nitroglycerin in early treatment, then another form
48
Long acting forms for prophylaxis◦ Erythrityl tetranitrate (Cardilate)◦ Pentaerythritol tetranitrate (PETN)
49
Objective 14: list the side effects of nitroglycerin
50
Tolerance Headache Postural hypotension Dizziness Weakness Syncope
◦ Don’t use alcohol with nitros
51
Nitrates can increase intraocular and/or intracranial pressure
52
Objective 15: identify the nursing responsibilities associated with administering the nitroglycerin preparations
53
Teach: when angina occurs, take 3 tabs in 15 min; if no pain relief, call 911
Keep nitro in original container, cap tightly closed
Store in cool, dry place Rotate sites of topical applications Monitor BP during therapy
54
Shelf-life is 6 months. If burning/stinging sensation under tongue, drug still potent
Replace 3 months after opening bottle
55
Objective 16: identify the beta-adrenergic blocker used to treat angina
56
57
Examples: propranolol, Atenolol Decrease heart rate, contractility
◦ Results in reduction of myocardial oxygen consumption
◦ Better if used with nitrates Can not use in COPD, CHF, heart block,
bradycardia, DM
58
When used with nitrates, hypotensive episodes more likely to occur
Drugs used◦ Atenolol (Tenormin)--prototype◦ Metoprolol (Lopressor)◦ Nadolol (Corgard)◦ Propranolol (Inderal)
59
Objective 17: identify the calcium channel blockers used to treat angina
60
61
Nifedipine (Adalat, Procardia) Diltiazem HCl (Cardizem, Dilacor SR)--
prototype Verapamil (Calan, Isoptin) Bepridil (Vascor) Nicardipine HCl (Cardene)
Examples: calcium channel blockers
62
These drugs create coronary vasodilation, increased coronary blood flow, lowered blood pressure, increased cardiac output, and relax coronary artery spasms
63
Objective 18: identify the ACE inhibitors used to treat angina
64
65
The angiotensin-converting enzyme inhibitors decrease myocardial oxygen demands
66
Captopril (Capoten) Lisinopril (Prinivil)--prototype Ramipril (Altace)
Examples: ACE inhibitors
67
Objective 19: nursing care
68
Frequency, nature, precipitants of angina attack
Lifestyle changes made Effectiveness of coronary vasodilators in
relief of pain Monitor VS, esp. BP
Assessment
69
Ineffective tissue perfusion, cardiac function RT angina
Risk for injury RT side effects of coronary vasodilators
Deficient knowledge RT health alteration and medication regimen
Nursing diagnoses
70
What teaching is done for clients taking nitroglycerin?
What teaching is done for clients taking calcium channel blockers, ACE inhibitors, beta blockers?
What will the nurse monitor when clients are on these medications?
Implementation